Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Pirillo

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Cardiology Clinics|April 4, 2018
Proprotein Convertase Subtilisin Kexin 9 InhibitorsAngela Pirillo, Alberico Luigi Catapano
Current Atherosclerosis Reports|February 27, 2026
Upfront Combination or Stepwise Escalation: Personalising LDL-C Reduction in Clinical PracticeAngela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|March 27, 2026
From Child to Family: Rethinking Cascade Screening for Elevated Lipoprotein(a)Angela Pirillo, Alberico L Catapano
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemiaAngela Pirillo, Alberico L Catapano
European Heart Journal|August 14, 2021
Lipoprotein remnants: to be or not to beAngela Pirillo, Alberico Luigi Catapano
Atherosclerosis. Supplements|July 19, 2017
Pitavastatin and HDL: Effects on plasma levels and function(s)Angela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|May 9, 2026
Homozygous familial hypercholesterolemia: Will new LDL-C-lowering drugs replace lipoprotein apheresis?Angela Pirillo, Alberico L Catapano
European Heart Journal|July 21, 2019
Statins increase Lp(a) plasma level: is this clinically relevant?Angela Pirillo, Alberico Luigi Catapano
European Journal of Preventive Cardiology|November 7, 2024
Saturated vs. unsaturated fatty acids: should we reconsider their cardiovascular effects?Angela Pirillo, Alberico L Catapano
Cardiovascular Research|July 22, 2025
PCSK9 reloaded: sirtuin-1 as a post-translational checkpoint for LDL-C controlAngela Pirillo, Alberico L Catapano
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Cardiology Clinics|April 4, 2018
Proprotein Convertase Subtilisin Kexin 9 InhibitorsAngela Pirillo, Alberico Luigi Catapano
Current Atherosclerosis Reports|February 27, 2026
Upfront Combination or Stepwise Escalation: Personalising LDL-C Reduction in Clinical PracticeAngela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|March 27, 2026
From Child to Family: Rethinking Cascade Screening for Elevated Lipoprotein(a)Angela Pirillo, Alberico L Catapano
Current Opinion in Endocrinology, Diabetes, and Obesity|January 4, 2022
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemiaAngela Pirillo, Alberico L Catapano
European Heart Journal|August 14, 2021
Lipoprotein remnants: to be or not to beAngela Pirillo, Alberico Luigi Catapano
Atherosclerosis. Supplements|July 19, 2017
Pitavastatin and HDL: Effects on plasma levels and function(s)Angela Pirillo, Alberico L Catapano
European Journal of Preventive Cardiology|May 9, 2026
Homozygous familial hypercholesterolemia: Will new LDL-C-lowering drugs replace lipoprotein apheresis?Angela Pirillo, Alberico L Catapano
European Heart Journal|July 21, 2019
Statins increase Lp(a) plasma level: is this clinically relevant?Angela Pirillo, Alberico Luigi Catapano
European Journal of Preventive Cardiology|November 7, 2024
Saturated vs. unsaturated fatty acids: should we reconsider their cardiovascular effects?Angela Pirillo, Alberico L Catapano
Cardiovascular Research|July 22, 2025
PCSK9 reloaded: sirtuin-1 as a post-translational checkpoint for LDL-C controlAngela Pirillo, Alberico L Catapano
Pageof 12